Matches in SemOpenAlex for { <https://semopenalex.org/work/W2748075817> ?p ?o ?g. }
- W2748075817 endingPage "2093" @default.
- W2748075817 startingPage "2084" @default.
- W2748075817 abstract "Naringenin (NAR) is a natural predominant flavanone and has a wide range of pharmacological activities. The aim of this study was to investigate the protective mechanisms of NAR on RANKL‐induced osteoclastogenesis and osteoclast bone resorption. T cells were divided into four groups under different concentrations of NAR (0, 25, 50, 100 µM). CD4 + T cell subsets in different groups were evaluated by flow cytometry. TRAP staining, pit formation assays and F‐actin ring immunofluorescent staining were performed. In addition, gene expression of osteoclast‐specific markers was analyzed by qPCR and Western blot. Our results showed that compared with the control group, there were relatively fewer Th1 and Th17 cells and more Th2 cells and Treg cells in the NAR groups. Besides, the number of TRAP‐positive multinucleated osteoclasts, the areas of bone resorption pits and the size and number of F‐actin rings were notably decreased in the bone marrow macrophages (BMMs) treated with T‐cell supernatant containing NAR. Moreover, NAR treatment dramatically reduced the expressions of cathepsin K, c‐Fos, DC‐STAMP, NFATc1, TRAP, and V‐ATPase d2 at mRNA and protein levels. However, these effects were abolished by adding a neutralizing antibody against IL‐4. In conclusion, NAR suppressed RANKL‐induced osteoclastogenesis and osteoclast bone resorption by promoting the release of IL‐4 from T cells." @default.
- W2748075817 created "2017-08-31" @default.
- W2748075817 creator A5001663974 @default.
- W2748075817 creator A5008510580 @default.
- W2748075817 creator A5008618057 @default.
- W2748075817 creator A5011258773 @default.
- W2748075817 creator A5036222731 @default.
- W2748075817 creator A5061827319 @default.
- W2748075817 creator A5073554389 @default.
- W2748075817 creator A5078159886 @default.
- W2748075817 date "2017-09-18" @default.
- W2748075817 modified "2023-10-03" @default.
- W2748075817 title "Naringenin inhibits osteoclastogenesis through modulation of helper T cells‐secreted IL‐4" @default.
- W2748075817 cites W1119763100 @default.
- W2748075817 cites W1511075257 @default.
- W2748075817 cites W1555276708 @default.
- W2748075817 cites W1663755076 @default.
- W2748075817 cites W1964066819 @default.
- W2748075817 cites W1978432820 @default.
- W2748075817 cites W1980888912 @default.
- W2748075817 cites W1982726533 @default.
- W2748075817 cites W1994799740 @default.
- W2748075817 cites W1996447764 @default.
- W2748075817 cites W1997487210 @default.
- W2748075817 cites W2003287315 @default.
- W2748075817 cites W2012267828 @default.
- W2748075817 cites W2013070726 @default.
- W2748075817 cites W2016704225 @default.
- W2748075817 cites W2022412700 @default.
- W2748075817 cites W2037845870 @default.
- W2748075817 cites W2039467806 @default.
- W2748075817 cites W2041517379 @default.
- W2748075817 cites W2041934573 @default.
- W2748075817 cites W2043132168 @default.
- W2748075817 cites W2050079246 @default.
- W2748075817 cites W2060013770 @default.
- W2748075817 cites W2064674411 @default.
- W2748075817 cites W2074661703 @default.
- W2748075817 cites W2078578902 @default.
- W2748075817 cites W2087166222 @default.
- W2748075817 cites W2090848871 @default.
- W2748075817 cites W2096819701 @default.
- W2748075817 cites W2113580836 @default.
- W2748075817 cites W2113736876 @default.
- W2748075817 cites W2123993322 @default.
- W2748075817 cites W2124273389 @default.
- W2748075817 cites W2128144041 @default.
- W2748075817 cites W2129176808 @default.
- W2748075817 cites W2132897787 @default.
- W2748075817 cites W2137788383 @default.
- W2748075817 cites W2137830201 @default.
- W2748075817 cites W2144120552 @default.
- W2748075817 cites W2146195810 @default.
- W2748075817 cites W2149827038 @default.
- W2748075817 cites W2161749195 @default.
- W2748075817 cites W2163700030 @default.
- W2748075817 cites W2171115168 @default.
- W2748075817 cites W2326114476 @default.
- W2748075817 cites W2416299657 @default.
- W2748075817 cites W594594735 @default.
- W2748075817 cites W603338907 @default.
- W2748075817 doi "https://doi.org/10.1002/jcb.26370" @default.
- W2748075817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28834554" @default.
- W2748075817 hasPublicationYear "2017" @default.
- W2748075817 type Work @default.
- W2748075817 sameAs 2748075817 @default.
- W2748075817 citedByCount "15" @default.
- W2748075817 countsByYear W27480758172018 @default.
- W2748075817 countsByYear W27480758172019 @default.
- W2748075817 countsByYear W27480758172020 @default.
- W2748075817 countsByYear W27480758172022 @default.
- W2748075817 countsByYear W27480758172023 @default.
- W2748075817 crossrefType "journal-article" @default.
- W2748075817 hasAuthorship W2748075817A5001663974 @default.
- W2748075817 hasAuthorship W2748075817A5008510580 @default.
- W2748075817 hasAuthorship W2748075817A5008618057 @default.
- W2748075817 hasAuthorship W2748075817A5011258773 @default.
- W2748075817 hasAuthorship W2748075817A5036222731 @default.
- W2748075817 hasAuthorship W2748075817A5061827319 @default.
- W2748075817 hasAuthorship W2748075817A5073554389 @default.
- W2748075817 hasAuthorship W2748075817A5078159886 @default.
- W2748075817 hasConcept C101990758 @default.
- W2748075817 hasConcept C104317684 @default.
- W2748075817 hasConcept C134018914 @default.
- W2748075817 hasConcept C146562846 @default.
- W2748075817 hasConcept C153911025 @default.
- W2748075817 hasConcept C185592680 @default.
- W2748075817 hasConcept C202751555 @default.
- W2748075817 hasConcept C2776033226 @default.
- W2748075817 hasConcept C2776415932 @default.
- W2748075817 hasConcept C2776848411 @default.
- W2748075817 hasConcept C2778004101 @default.
- W2748075817 hasConcept C2779054382 @default.
- W2748075817 hasConcept C2779428903 @default.
- W2748075817 hasConcept C553184892 @default.
- W2748075817 hasConcept C55493867 @default.
- W2748075817 hasConcept C673006 @default.
- W2748075817 hasConcept C86803240 @default.